T1	CHEM 30 42	pravastatina
#1	AnnotatorNotes T1	C0085542; pravastatin; Organic Chemical · Pharmacologic Substance
T2	PROC 2273 2300	biomarcadores inflamatorios
#2	AnnotatorNotes T2	C3805088; Inflammatory marker test; Laboratory Procedure
T3	PROC 67 97	niveles de proteína C reactiva
#3	AnnotatorNotes T3	C0201657; C-reactive protein measurement; Laboratory Procedure
T4	ANAT 107 117	neutrófilo
#4	AnnotatorNotes T4	C0027950; neutrophil; Cell
T5	ANAT 118 127	linfocito
#5	AnnotatorNotes T5	C0024264; Lymphocyte; Cell
T6	PROC 153 164	mastectomía
#6	AnnotatorNotes T6	C0024881; Mastectomy; Therapeutic or Preventive Procedure
T7	DISO 169 183	cáncer de mama
#7	AnnotatorNotes T7	C0006142; Malignant neoplasm of breast; Neoplastic Process | C0678222; Breast Carcinoma; Neoplastic Process
T8	DISO 267 281	tumour maligno
#8	AnnotatorNotes T8	C0006826; Malignant Neoplasms; Neoplastic Process
T9	DISO 202 216	cáncer de mama
#9	AnnotatorNotes T9	C0006142; Malignant neoplasm of breast; Neoplastic Process | C0678222; Breast Carcinoma; Neoplastic Process
T10	DISO 331 341	neoplasias
#10	AnnotatorNotes T10	C0006826; Malignant Neoplasms; Neoplastic Process | C0027651; Neoplasms; Neoplastic Process | C1882062; Neoplastic disease; Neoplastic Process
T11	DISO 401 423	respuesta inflamatoria
#11	AnnotatorNotes T11	C1155266; Inflammatory Response; Pathologic Function
T12	PROC 440 455	acto quirúrgico
#12	AnnotatorNotes T12	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T13	PROC 470 481	tratamiento
#13	AnnotatorNotes T13	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T14	DISO 2287 2300	inflamatorios
#14	AnnotatorNotes T14	C0021368; Inflammation; Pathologic Function
T15	ANAT 520 534	cardiovascular
#15	AnnotatorNotes T15	C0007226; Cardiovascular system; Body System | C3887460; Cardiovascular; Body Location or Region
T16	PROC 884 887	INL
#16	AnnotatorNotes T16	C4683674; Neutrophil to Lymphocyte Ratio Measurement; Laboratory Procedure
T17	DISO 604 614	metástasis
#17	AnnotatorNotes T17	C0027627; Neoplasm Metastasis; Neoplastic Process | C4255448; Metastasis; Pathologic Function
T18	CHEM 673 685	pravastatina
#18	AnnotatorNotes T18	C0085542; pravastatin; Organic Chemical · Pharmacologic Substance
T19	DISO 767 784	trauma quirúrgico
T20	PROC 774 784	quirúrgico
#19	AnnotatorNotes T20	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T21	PROC 813 843	niveles de proteína C reactiva
#20	AnnotatorNotes T21	C0201657; C-reactive protein measurement; Laboratory Procedure
T22	ANAT 862 872	neutrófilo
#21	AnnotatorNotes T22	C0027950; neutrophil; Cell
T23	ANAT 873 882	linfocito
#22	AnnotatorNotes T23	C0024264; Lymphocyte; Cell
T24	DISO 906 920	cáncer de mama
#23	AnnotatorNotes T24	C0006142; Malignant neoplasm of breast; Neoplastic Process | C0678222; Breast Carcinoma; Neoplastic Process
T25	PROC 933 952	mastectomía radical
#24	AnnotatorNotes T25	C0024884; Mastectomy, Radical; Therapeutic or Preventive Procedure | C0086383; Halsted Mastectomy; Therapeutic or Preventive Procedure
T26	PROC 964 1016	Ensayo clínico prospectivo aleatorizado simple ciego
#25	AnnotatorNotes T26	C0033522; Prospective Studies; Research Activity + C0150108; Blinded; Research Activity + C0206034; Clinical Trials, Randomized; Research Activity
T27	DISO 1034 1048	cáncer de mama
#26	AnnotatorNotes T27	C0006142; Malignant neoplasm of breast; Neoplastic Process | C0678222; Breast Carcinoma; Neoplastic Process
T28	PROC 1061 1072	mastectomía
#27	AnnotatorNotes T28	C0024881; Mastectomy; Therapeutic or Preventive Procedure
T29	CHEM 1173 1185	pravastatina
#28	AnnotatorNotes T29	C0085542; pravastatin; Organic Chemical · Pharmacologic Substance
T30	PROC 1237 1264	biomarcadores inflamatorios
#29	AnnotatorNotes T30	C3805088; Inflammatory marker test; Laboratory Procedure
T31	DISO 1251 1264	inflamatorios
#30	AnnotatorNotes T31	C0021368; Inflammation; Pathologic Function
T32	PROC 1477 1496	mastectomía radical
#31	AnnotatorNotes T32	C0024884; Mastectomy, Radical; Therapeutic or Preventive Procedure | C0086383; Halsted Mastectomy; Therapeutic or Preventive Procedure
T33	CHEM 1631 1643	pravastatina
#32	AnnotatorNotes T33	C0085542; pravastatin; Organic Chemical · Pharmacologic Substance
T34	CHEM 1713 1725	pravastatina
#33	AnnotatorNotes T34	C0085542; pravastatin; Organic Chemical · Pharmacologic Substance
T35	ANAT 1913 1923	neutrófilo
#34	AnnotatorNotes T35	C0027950; neutrophil; Cell
T36	ANAT 1924 1933	linfocito
#35	AnnotatorNotes T36	C0024264; Lymphocyte; Cell
T37	CHEM 2047 2059	pravastatina
#36	AnnotatorNotes T37	C0085542; pravastatin; Organic Chemical · Pharmacologic Substance
T38	PROC 2163 2177	administración
#37	AnnotatorNotes T38	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T39	PROC 2318 2337	proteína C reactiva
#38	AnnotatorNotes T39	C0201657; C-reactive protein measurement; Laboratory Procedure
T40	CHEM 2352 2359	fármaco
#39	AnnotatorNotes T40	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T41	PROC 2432 2451	mastectomía radical
#40	AnnotatorNotes T41	C0024884; Mastectomy, Radical; Therapeutic or Preventive Procedure | C0086383; Halsted Mastectomy; Therapeutic or Preventive Procedure
T42	CHEM 78 97	proteína C reactiva
#41	AnnotatorNotes T42	C0006560; C-reactive protein; Amino Acid, Peptide, or Protein · Immunologic Factor
T43	PROC 100 127	índice neutrófilo/linfocito
#42	AnnotatorNotes T43	C4683674; Neutrophil to Lymphocyte Ratio Measurement; Laboratory Procedure
T44	ANAT 179 183	mama
#43	AnnotatorNotes T44	C0006141; Breast; Body Part, Organ, or Organ Component | C1268990; Entire breast; Body Part, Organ, or Organ Component
T45	ANAT 212 216	mama
#44	AnnotatorNotes T45	C0006141; Breast; Body Part, Organ, or Organ Component | C1268990; Entire breast; Body Part, Organ, or Organ Component
T46	DISO 566 585	recidivas tumorales
#45	AnnotatorNotes T46	C0521158; Recurrent tumor; Neoplastic Process
T47	DISO 709 741	respuesta inflamatoria sistémica
#46	AnnotatorNotes T47	C3554550; Systemic inflammatory response; Pathologic Function
T48	CHEM 824 843	proteína C reactiva
#47	AnnotatorNotes T48	C0006560; C-reactive protein; Amino Acid, Peptide, or Protein · Immunologic Factor
T49	PROC 845 848	PCR
#48	AnnotatorNotes T49	C0201657; C-reactive protein measurement; Laboratory Procedure
T50	PROC 855 882	índice neutrófilo/linfocito
#49	AnnotatorNotes T50	C4683674; Neutrophil to Lymphocyte Ratio Measurement; Laboratory Procedure
T51	ANAT 916 920	mama
#50	AnnotatorNotes T51	C0006141; Breast; Body Part, Organ, or Organ Component | C1268990; Entire breast; Body Part, Organ, or Organ Component
T52	ANAT 1044 1048	mama
#51	AnnotatorNotes T52	C0006141; Breast; Body Part, Organ, or Organ Component | C1268990; Entire breast; Body Part, Organ, or Organ Component
T53	PROC 1777 1780	PCR
#52	AnnotatorNotes T53	C0201657; C-reactive protein measurement; Laboratory Procedure
T54	PROC 1906 1933	índice neutrófilo linfocito
#53	AnnotatorNotes T54	C4683674; Neutrophil to Lymphocyte Ratio Measurement; Laboratory Procedure
T55	CHEM 2195 2207	pravastatina
#54	AnnotatorNotes T55	C0085542; pravastatin; Organic Chemical · Pharmacologic Substance
T56	Dose 11 26	una dosis única
T57	Date 43 56	preoperatoria
#55	AnnotatorNotes T57	C0445204; Preoperative; Temporal Concept | C2712277; Preoperative Period; Temporal Concept
T58	LIVB 131 140	pacientes
#56	AnnotatorNotes T58	C0030705; Patients; Patient or Disabled Group
T59	LIVB 285 292	mujeres
#57	AnnotatorNotes T59	C0043210; Woman; Population Group
T60	Age 293 311	mayores de 25 años
T61	LIVB 317 326	pacientes
#58	AnnotatorNotes T61	C0030705; Patients; Patient or Disabled Group
T65	Spec_cue 556 565	riesgo de
T66	LIVB 892 901	pacientes
#59	AnnotatorNotes T66	C0030705; Patients; Patient or Disabled Group
T67	LIVB 1020 1029	pacientes
#60	AnnotatorNotes T67	C0030705; Patients; Patient or Disabled Group
T68	LIVB 1103 1111	paciente
#61	AnnotatorNotes T68	C0030705; Patients; Patient or Disabled Group
T69	Dose 1160 1169	una dosis
T70	Dose 1186 1191	20 mg
T71	Date 1192 1205	preoperatoria
#62	AnnotatorNotes T71	C0445204; Preoperative; Temporal Concept | C2712277; Preoperative Period; Temporal Concept
T73	Date 1265 1285	pre y posoperatorios
#63	AnnotatorNotes T73	C2712277; Preoperative Period; Temporal Concept + C0032790; Postoperative Period; Temporal Concept
T74	LIVB 1455 1464	pacientes
#64	AnnotatorNotes T74	C0030705; Patients; Patient or Disabled Group
T75	LIVB 1585 1598	grupo control
#65	AnnotatorNotes T75	C0009932; Control Groups; Group
T76	Age 1606 1615	56.9 años
T77	Age 1644 1653	53.4 años
T78	LIVB 1675 1684	pacientes
#66	AnnotatorNotes T78	C0030705; Patients; Patient or Disabled Group
T79	Dose 1700 1709	una dosis
T80	Date 1726 1739	preoperatoria
#67	AnnotatorNotes T80	C0445204; Preoperative; Temporal Concept | C2712277; Preoperative Period; Temporal Concept
T81	Dose 1740 1745	20 mg
T82	LIVB 1853 1866	grupo control
#68	AnnotatorNotes T82	C0009932; Control Groups; Group
T84	LIVB 2130 2143	grupo control
#69	AnnotatorNotes T84	C0009932; Control Groups; Group
T85	Date 2178 2191	preoperatoria
#70	AnnotatorNotes T85	C0445204; Preoperative; Temporal Concept | C2712277; Preoperative Period; Temporal Concept
T86	Dose 2208 2225	20 mg única dosis
T88	LIVB 2395 2404	pacientes
#71	AnnotatorNotes T88	C0030705; Patients; Patient or Disabled Group
A1	Assertion T46 Speculated
T62	Quantifier_or_Qualifier 1951 1982	estadísticamente significativos
A2	Assertion T62 Negated
#72	AnnotatorNotes T62	C0237881; Statistical Significance; Quantitative Concept
T63	Neg_cue 1941 1943	no
R1	Negation Arg1:T63 Arg2:T62	
R2	Has_Dose_or_Strength Arg1:T1 Arg2:T56	
R3	Overlap Arg1:T1 Arg2:T57	
T64	Observation 1 7	Efecto
#73	AnnotatorNotes T64	C1518681; Outcome of Therapy; Finding (?)
R4	Causes Arg1:T1 Arg2:T64	
R5	Experiences Arg1:T58 Arg2:T64	
R6	Experiences Arg1:T58 Arg2:T1	
R7	Experiences Arg1:T58 Arg2:T3	
R8	Experiences Arg1:T58 Arg2:T43	
R9	Experiences Arg1:T58 Arg2:T6	
R10	Experiences Arg1:T58 Arg2:T7	
R11	Location_of Arg1:T44 Arg2:T7	
R12	Before Arg1:T1 Arg2:T6	
R13	Location_of Arg1:T45 Arg2:T9	
R14	Experiences Arg1:T59 Arg2:T9	
R15	Experiences Arg1:T59 Arg2:T8	
T72	CONC 252 262	mortalidad
#74	AnnotatorNotes T72	C0026565; Mortality Vital Statistics; Quantitative Concept
R16	Has_Age Arg1:T59 Arg2:T60	
R17	Experiences Arg1:T61 Arg2:T10	
T83	Observation 362 384	estado proinflamatorio
R18	Experiences Arg1:T61 Arg2:T83	
R19	Overlap Arg1:T10 Arg2:T83	
R20	Experiences Arg1:T61 Arg2:T11	
R21	Causes Arg1:T12 Arg2:T11	
R22	Experiences Arg1:T61 Arg2:T12	
R23	Experiences Arg1:T61 Arg2:T13	
R24	Speculation Arg1:T65 Arg2:T46	
R28	Before Arg1:T83 Arg2:T17	
R29	Before Arg1:T10 Arg2:T17	
R30	Experiences Arg1:T61 Arg2:T46	
R31	Experiences Arg1:T61 Arg2:T17	
R33	Causes Arg1:T19 Arg2:T47	
R34	Causes Arg1:T20 Arg2:T19	
R39	Overlap Arg1:T47 Arg2:T24	
R40	Experiences Arg1:T66 Arg2:T25	
R41	Location_of Arg1:T51 Arg2:T24	
R42	Experiences Arg1:T66 Arg2:T24	
R43	Experiences Arg1:T66 Arg2:T16	
R44	Experiences Arg1:T66 Arg2:T50	
R45	Experiences Arg1:T66 Arg2:T49	
R46	Experiences Arg1:T66 Arg2:T21	
R47	Experiences Arg1:T66 Arg2:T18	
R48	Experiences Arg1:T66 Arg2:T47	
R49	Experiences Arg1:T66 Arg2:T19	
R50	Experiences Arg1:T67 Arg2:T27	
R51	Location_of Arg1:T52 Arg2:T27	
R52	Experiences Arg1:T67 Arg2:T28	
R53	Experiences Arg1:T68 Arg2:T28	
R54	Experiences Arg1:T68 Arg2:T27	
R55	Has_Dose_or_Strength Arg1:T29 Arg2:T69	
R56	Has_Dose_or_Strength Arg1:T29 Arg2:T70	
R57	Overlap Arg1:T29 Arg2:T71	
R59	Overlap Arg1:T30 Arg2:T73	
T90	CONC 1416 1425	T student
#77	AnnotatorNotes T90	C0871453; Students T Test; Intellectual Product
R61	Experiences Arg1:T74 Arg2:T32	
T91	Quantifier_or_Qualifier 1504 1513	incluidas
#78	AnnotatorNotes T91	C1512693; Inclusion; Qualitative Concept
R62	Has_Quantifier_or_Qualifier Arg1:T74 Arg2:T91	
R63	Has_Age Arg1:T75 Arg2:T76	
R64	Experiences Arg1:T78 Arg2:T34	
R65	Has_Dose_or_Strength Arg1:T34 Arg2:T79	
R66	Overlap Arg1:T34 Arg2:T80	
R67	Has_Dose_or_Strength Arg1:T34 Arg2:T81	
T92	Observation 1761 1780	elevación de la PCR
#79	AnnotatorNotes T92	C0742906; Elevated C-reactive protein; Finding
R68	Experiences Arg1:T78 Arg2:T92	
R69	Experiences Arg1:T78 Arg2:T53	
R70	Before Arg1:T34 Arg2:T92	
R71	Experiences Arg1:T82 Arg2:T92	
R72	Experiences Arg1:T82 Arg2:T53	
R73	Experiences Arg1:T84 Arg2:T54	
R77	Experiences Arg1:T78 Arg2:T54	
T93	CONC 1894 1901	cambios
#80	AnnotatorNotes T93	C0443172; Changed status; Quantitative Concept
R81	Used_for Arg1:T55 Arg2:T38	
R82	Has_Dose_or_Strength Arg1:T55 Arg2:T86	
R83	Overlap Arg1:T55 Arg2:T85	
R85	Experiences Arg1:T88 Arg2:T41	
R86	Experiences Arg1:T88 Arg2:T40	
R87	Experiences Arg1:T88 Arg2:T39	
R88	Experiences Arg1:T88 Arg2:T2	
R89	Experiences Arg1:T88 Arg2:T38	
R92	Causes Arg1:T25 Arg2:T47	
R93	Causes Arg1:T25 Arg2:T19	
R80	Has_Quantifier_or_Qualifier Arg1:T93 Arg2:T62	
R25	Before Arg1:T38 Arg2:T41	
R26	Overlap Arg1:T40 Arg2:T85	
R27	Used_for Arg1:T40 Arg2:T38	
A3	Experiencer T58 Patient
A4	Experiencer T59 Patient
A5	Experiencer T61 Patient
A6	Experiencer T66 Patient
A7	Experiencer T67 Patient
A8	Experiencer T68 Patient
A9	Experiencer T74 Patient
A10	Experiencer T75 Patient
A11	Experiencer T78 Patient
A12	Experiencer T82 Patient
A13	Experiencer T84 Patient
A14	Experiencer T88 Patient
R32	Has_Result_or_Value Arg1:T53 Arg2:T92	
